Shareholders’ Equity (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Shareholders’ Equity [Abstract] |
|
Schedule of Company's RSU Award Activity |
A
summary of the Company’s RSU award activity for the three and six months ended June 30, 2024 and 2023, respectively, is as
follows:
| |
Restricted Stock Units | | |
Weighted Average Grant Date Fair Value | |
Outstanding at December 31, 2023 | |
| 2,185,210 | | |
$ | 0.20 | |
Granted | |
| - | | |
| - | |
Vested | |
| (1,004,982 | ) | |
| 0.23 | |
Forfeited | |
| (68,500 | ) | |
| 0.13 | |
Outstanding at March 31, 2024 | |
| 1,111,728 | | |
$ | 0.18 | |
Granted | |
| - | | |
| - | |
Vested | |
| - | | |
| - | |
Forfeited | |
| - | | |
| - | |
Outstanding at June 30, 2024 | |
| 1,111,728 | | |
$ | 0.18 | |
| |
Restricted Stock Units | | |
Weighted Average Grant Date Fair Value | |
Outstanding at December 31, 2022 | |
| 1,453,857 | | |
$ | 0.30 | |
Granted | |
| 2,760,660 | | |
| 0.17 | |
Vested | |
| (1,877,932 | ) | |
| 0.23 | |
Forfeited | |
| - | | |
| - | |
Outstanding at March 31, 2023 | |
| 2,336,585 | | |
$ | 0.21 | |
Granted | |
| 755,500 | | |
| 0.10 | |
Vested | |
| (802,000 | ) | |
| 0.12 | |
Forfeited | |
| - | | |
| - | |
Outstanding at June 30, 2023 | |
| 2,290,085 | | |
$ | 0.21 | |
|
Schedule of Stock Option Activity |
A
summary of the Company’s stock option activity for the three and six months ended June 30, 2024, and 2023, respectively, is
as follows: | | Stock Option Shares | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Term | | | Aggregate Intrinsic Value | | Outstanding and exercisable at December 31, 2023 | | | 11,513,214 | | | $ | 0.17 | | | | 7.3 | | | $ | 1,962,017 | | Granted | | | 8,085,081 | | | | 0.05 | | | | 5.4 | | | | - | | Forfeited | | | - | | | | - | | | | - | | | | - | | Outstanding and exercisable at March 31, 2024 | | | 19,598,295 | | | $ | 0.12 | | | | 6.4 | | | $ | 2,019,574 | | Granted | | | - | | | | - | | | | - | | | | - | | Forfeited | | | - | | | | - | | | | - | | | | - | | Outstanding and exercisable at June 30, 2024 | | | 19,598,295 | | | $ | 0.12 | | | | 6.1 | | | $ | 2,038,489 | | | | Stock Option Shares | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Term | | | Aggregate Intrinsic Value | | Outstanding and exercisable at December 31, 2022 | | | 8,500,000 | | | $ | 0.18 | | | | 8.5 | | | $ | 1,579,108 | | Granted | | | - | | | | - | | | | - | | | | - | | Forfeited | | | - | | | | - | | | | - | | | | - | | Outstanding and exercisable at March 31, 2023 | | | 8,500,000 | | | $ | 0.18 | | | | 8.0 | | | $ | 1,579,108 | | Granted | | | - | | | | - | | | | - | | | | - | | Forfeited | | | - | | | | - | | | | - | | | | - | | Outstanding and exercisable at June 30, 2023 | | | 8,500,000 | | | $ | 0.18 | | | | 7.7 | | | $ | 1,579,108 | |
|
Schedule of Warrant Activity |
A
summary of the Company’s warrant activity for the three months ended June 30, 2024 and 2023, respectively, is as follows: | | Warrant Shares | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Term | | | Aggregate Fair Value | | Outstanding and exercisable at December 31, 2023 | | | 51,662,689 | | | $ | 0.45 | | | | 2.9 | | | $ | 2,817,424 | | Granted | | | - | | | | - | | | | - | | | | - | | Exercised | | | - | | | | - | | | | - | | | | - | | Expired | | | - | | | | - | | | | - | | | | - | | Outstanding and exercisable at March 31, 2024 | | | 51,662,689 | | | $ | 0.45 | | | | 2.7 | | | $ | 2,817,424 | | Granted | | | 28,747,494 | | | | 0.06 | | | | - | | | | 770,218 | | Exercised | | | - | | | | - | | | | - | | | | - | | Expired | | | - | | | | - | | | | - | | | | - | | Outstanding and exercisable at June 30, 2024 | | | 80,410,183 | | | $ | 0.31 | | | | 3.2 | | | $ | 3,587,642 | | | | Warrant Shares | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Term | | | Aggregate Fair Value | | Outstanding and exercisable at December 31, 2022 | | | 73,950,000 | | | $ | 0.40 | | | | 1.0 | | | $ | 1,867,754 | | Granted | | | - | | | | - | | | | - | | | | - | | Exercised | | | - | | | | - | | | | - | | | | - | | Expired | | | (15,000,000 | ) | | | - | | | | - | | | | - | | Outstanding and exercisable at March 31, 2023 | | | 58,950,000 | | | $ | 0.40 | | | | 0.9 | | | $ | 1,867,754 | | Granted | | | 2,540,550 | | | | 0.25 | | | | - | | | | 179,026 | | Exercised | | | - | | | | - | | | | - | | | | - | | Expired | | | (9,500,000 | ) | | | 0.40 | | | | - | | | | - | | Outstanding and exercisable at June 30, 2023 | | | 51,990,550 | | | $ | 0.39 | | | | 0.9 | | | $ | 2,046,780 | |
|